Cargando…
Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening
(1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare ar...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737650/ https://www.ncbi.nlm.nih.gov/pubmed/36498696 http://dx.doi.org/10.3390/jcm11237121 |
_version_ | 1784847343610232832 |
---|---|
author | Romero-Aroca, Pedro Baget-Bernaldiz, Marc Sagarra, Ramon Hervás, Esther Blasco, Reyes Molina, Julia Moreno, Empar F. Garcia-Curto, Eugeni |
author_facet | Romero-Aroca, Pedro Baget-Bernaldiz, Marc Sagarra, Ramon Hervás, Esther Blasco, Reyes Molina, Julia Moreno, Empar F. Garcia-Curto, Eugeni |
author_sort | Romero-Aroca, Pedro |
collection | PubMed |
description | (1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored. |
format | Online Article Text |
id | pubmed-9737650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97376502022-12-11 Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening Romero-Aroca, Pedro Baget-Bernaldiz, Marc Sagarra, Ramon Hervás, Esther Blasco, Reyes Molina, Julia Moreno, Empar F. Garcia-Curto, Eugeni J Clin Med Article (1) Background: Diabetic retinopathy (DR) is a complication of diabetes mellitus (DM), screening programs of which have been affected by the COVID-19 pandemic. The aim of the present study was to determine the impact of the COVID-19 pandemic on the screening of diabetes patients in our healthcare area (HCA). (2) Methods: We carried out a retrospective study of patients with DM who had attended the DR screening program between January 2015 and June 2022. We studied attendance, DM metabolic control and DR incidence. (3) Results: Screening for DR decreased in the first few months of the pandemic. The incidence of mild and moderate DR remained stable throughout the study, and we observed little increase in severe DR, proliferative DR and neovascular glaucoma during 2021 and 2022. (4) Conclusions: The current study shows that during the COVID-19 pandemic, screening program attendance decreased during the year 2020, which then recovered in 2021. Regarding the most severe forms of DR, a slight increase in cases was observed, beginning in the year 2021. Nevertheless, we aimed to improve the telemedicine systems, since the conditions of a significant proportion of the studied patients worsened during the pandemic; these patients are likely those who were already poorly monitored. MDPI 2022-11-30 /pmc/articles/PMC9737650/ /pubmed/36498696 http://dx.doi.org/10.3390/jcm11237121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Romero-Aroca, Pedro Baget-Bernaldiz, Marc Sagarra, Ramon Hervás, Esther Blasco, Reyes Molina, Julia Moreno, Empar F. Garcia-Curto, Eugeni Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening |
title | Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening |
title_full | Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening |
title_fullStr | Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening |
title_full_unstemmed | Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening |
title_short | Impact of the COVID-19 Pandemic on the Metabolic Control of Diabetic Patients in Diabetic Retinopathy and Its Screening |
title_sort | impact of the covid-19 pandemic on the metabolic control of diabetic patients in diabetic retinopathy and its screening |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737650/ https://www.ncbi.nlm.nih.gov/pubmed/36498696 http://dx.doi.org/10.3390/jcm11237121 |
work_keys_str_mv | AT romeroarocapedro impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT bagetbernaldizmarc impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT sagarraramon impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT hervasesther impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT blascoreyes impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT molinajulia impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT morenoemparf impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening AT garciacurtoeugeni impactofthecovid19pandemiconthemetaboliccontrolofdiabeticpatientsindiabeticretinopathyanditsscreening |